Waldron Private Wealth LLC
- SEC CIK
- 0001598180
- Latest filing
- Jul 20, 2026
NBSE holding history
NeuBase Therapeutics, Inc. in every 13F filed by Waldron Private Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBSE overviewAll 13F holders of NBSEFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −3,981−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q1 2023 | 79,620 | $14.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 79,620 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 79,620 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 79,620 | $83.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 79,620 | $149.0K | <0.1% | +59,532+296.4% | Added | Holders |
| Q4 2021 | 20,088 | $56.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 20,088 | $72.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 20,088 | $96.0K | <0.1% | +20,088 | New | Holders |